SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (1195)8/10/1997 2:03:00 AM
From: Vector1   of 1762
 
<<Looking at other molecules in IDEC's pipeline, I find the Abs to B7 and CD40Ligand particularly interesting given the recent PNAS article out of U. Wisconsin/Naval Hospital/GI/Biogen on a model of organ transplantation in rhesus.>>

PB and Richard I also noticed the press release regarding the organ transplantation in rhesus. As a holder of BGEN and IDPH OCT calls I am particularly interested. I would very much appreciate it if you would go into more detail on your view of the significance of the findings for both companies.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News